Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Relationship Between Social Determinants and Opioid Use Disorder Treatment Outcomes by Gender

This study aims to identify social correlates of OUD treatment outcomes from five key areas of social determinants separately for men and women receiving buprenorphine for OUD.
Original research | 2022
About PWUD, Illegal drugs, Substitution/OAT, Sex/Gender

Smart Syringe Vending Machines: Research Capabilities and Implications for Research Data Collection

Syringe vending machines (SVMs) are intended to supplement the standard syringe exchange programs to access hard-to-reach groups and to cover unserved geographical areas.
Original research | 2021
About PWUD, Social services, Digital health

Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial

Heroin-assisted treatment is eff ective for methadone treatment-refractory heroin-dependent patients, but continued comorbid cocaine dependence remains problematic.
Original research | 2016
Safer supply, About PWUD, Outcomes, Illegal drugs, Stimulants

The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction

During the pandemic, addiction support became more challenging, as existing health care models had changed or been completely abolished.
Original research | 2022
Overdose, Mortality, Policy/Regulatory, About prescribers, Social services, Workplace, Mental health

Toward a positive psychology of psychoactive drug use

This article advances the proposition that contemporary perspectives on psychoactive drug use are epistemologically limited and that a broadened conceptualization of substance use would aid the develo
Original research | 2021
Policy/Regulatory, Advocacy, About PWUD, Illegal drugs

Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl, and pharmaceutical fentanyl in opioid overdose deaths, 38 states and the District of Columbia, January 2018–December 2019

This study aimed to determine whether integrating death certificate data with medical examiner/coroner reports, including postmortem toxicology and death investigation findings, would enhance identifi
Original research | 2021
Overdose, Mortality, Evidence base, Illegal drugs

Wound Bed Preparation 2021

To present the 2021 update of the Wound Bed Preparation paradigm
Guidelines | 2021
Clinical guidance, Wrap-around services, About prescribers, Chronic pain, Injecting drugs

Associations between patient experience and clinical outcomes in substance use disorder clinics: Findings from the veterans outcomes assessment survey

Patient-centeredness is a cornerstone of substance use disorder (SUD) treatment.
Original research | 2022
About prescribers, Barriers and enablers, Substitution/OAT, Transitions in care/treatment

Boîte à outils pour la mise en place d’un site répondant à un besoin urgent en matière de santé publique (SBUSP)

Guide or handbook | 2021
Overdose, Clinical guidance, Harm reduction, About prescribers, Social services, Illegal drugs, SCS/OPS

Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People

The objective of this study was to identify variables associated with buprenorphine/naloxone retention among Alaska Native and American Indian people with opioid use disorder
Original research | 2021
Equity, About PWUD, Outcomes, Illegal drugs, Indigenous, Substitution/OAT

Causes of death among people who used illicit opioids in England, 2001–18: a matched cohort study

In many countries, the average age of people who use illicit opioids, such as heroin, is increasing.
Original research | 2021
Mortality, About PWUD, Outcomes, Illegal drugs

Characterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”

This study explores how PWUS understand, experience, and respond to overamping.
Original research | 2022
Overdose, About PWUD, Illegal drugs, Stimulants

Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder

The study examined trends in use of tele-buprenorphine and compared demographic and clinical characteristics in patients who received tele-buprenorphine versus those who received in-person treatment o
Original research | 2022
About prescribers, Rural/remote, Substitution/OAT, Digital health

Connecting: A Guide to Using Harm Reduction Supplies as Engagement Tools

Connecting - A Guide to Using Harm Reduction Supplies as Engagement Tools was developed to support frontline workers in their day to day work.

Guide or handbook | 2020
Harm reduction, Wrap-around services, About prescribers, Social services, Illegal drugs, Stimulants, Injecting drugs

Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019

Is there variation by sex and by racial and ethnic subgroups in rates of opioid overdose deaths among older adults over time?
Original research | 2022
Overdose, Mortality, Equity, About PWUD, Illegal drugs, Sex/Gender

Imprisonment, community sanctions and mortality by cause of death among patients with substance use disorder – a 28-year follow-up using Finnish register data

Using data on Finnish individuals who had sought treatment for substance use, we studied the association between criminal sanctions with cause-specific mortality.
Original research | 2022
Mortality, About PWUD, Outcomes, Legal system/law enforcement

Mortality involving New Psychoactive Substances across Europe, 2016-2017

This study aims to estimate the mortality related to new psychoactive substances (NPS) in Europe in 2016 and 2017.
Original research | 2022
Overdose, Mortality, About PWUD, Illegal drugs

Navigating conflicting value systems: a grounded theory of the process of public health equity work in the context of mental health promotion and prevention of harms of substance use

The aim of the study was to explore how public health providers identified and navigated ethical issues and their management related to promoting health equity within services focused on mental health
Original research | 2022
Equity, About prescribers, Social services, Workplace, Mental health

Persistence of significant pain interference following substance use disorder remission: Negative association with psychosocial and physical recovery

Although substance use disorder (SUD) is frequently complicated by pain, the prevalence and correlates of persistent pain and dysfunction following SUD remission have not been studied.
Original research | 2022
About PWUD, Illegal drugs, Chronic pain

Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder

For individuals desiring MOUD, the final step in the cascade is filling a written prescription, and fill rates have not been described.
Original research | 2022
About PWUD, Barriers and enablers, Outcomes, Substitution/OAT, Transitions in care/treatment

Affiner votre recherche

Mots clés
Format
Région